Delayed
Bombay S.E.
05:19:15 28/06/2024 BST
|
5-day change
|
1st Jan Change
|
92.59
INR
|
-0.17%
|
|
-6.52%
|
-8.33%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
459.8
|
282.2
|
231.3
|
610.6
|
1,146
|
2,515
|
Enterprise Value (EV)
1 |
517.4
|
363.6
|
311.6
|
696.5
|
1,262
|
2,673
|
P/E ratio
|
-26.7
x
|
-24.3
x
|
45.4
x
|
20.6
x
|
40.6
x
|
811
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.59
x
|
0.36
x
|
0.26
x
|
0.77
x
|
1.01
x
|
2.25
x
|
EV / Revenue
|
0.66
x
|
0.46
x
|
0.35
x
|
0.88
x
|
1.11
x
|
2.39
x
|
EV / EBITDA
|
-25.9
x
|
56.8
x
|
14.9
x
|
11.8
x
|
25.9
x
|
112
x
|
EV / FCF
|
-30.6
x
|
-13.5
x
|
-27.7
x
|
-42.3
x
|
-26.4
x
|
-54.6
x
|
FCF Yield
|
-3.26%
|
-7.4%
|
-3.61%
|
-2.36%
|
-3.78%
|
-1.83%
|
Price to Book
|
1.56
x
|
0.99
x
|
0.8
x
|
1.91
x
|
3.29
x
|
7.16
x
|
Nbr of stocks (in thousands)
|
24,326
|
24,326
|
24,326
|
24,326
|
24,326
|
24,326
|
Reference price
2 |
18.90
|
11.60
|
9.510
|
25.10
|
47.10
|
103.4
|
Announcement Date
|
03/09/18
|
29/08/19
|
04/09/20
|
06/09/21
|
05/09/22
|
07/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
780.2
|
794
|
896.3
|
792.5
|
1,136
|
1,119
|
EBITDA
1 |
-20
|
6.4
|
20.9
|
59.1
|
48.7
|
23.9
|
EBIT
1 |
-27.8
|
-3.1
|
10.3
|
48.2
|
37.9
|
11.7
|
Operating Margin
|
-3.56%
|
-0.39%
|
1.15%
|
6.08%
|
3.34%
|
1.05%
|
Earnings before Tax (EBT)
1 |
-16.5
|
-9.8
|
5.1
|
29.9
|
28.3
|
3.1
|
Net income
1 |
-17.2
|
-11.6
|
5.1
|
29.6
|
28.3
|
3.1
|
Net margin
|
-2.2%
|
-1.46%
|
0.57%
|
3.74%
|
2.49%
|
0.28%
|
EPS
2 |
-0.7088
|
-0.4769
|
0.2097
|
1.217
|
1.160
|
0.1274
|
Free Cash Flow
1 |
-16.89
|
-26.89
|
-11.25
|
-16.46
|
-47.72
|
-48.99
|
FCF margin
|
-2.16%
|
-3.39%
|
-1.26%
|
-2.08%
|
-4.2%
|
-4.38%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
03/09/18
|
29/08/19
|
04/09/20
|
06/09/21
|
05/09/22
|
07/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
57.6
|
81.4
|
80.3
|
85.9
|
117
|
158
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.88
x
|
12.72
x
|
3.842
x
|
1.453
x
|
2.392
x
|
6.607
x
|
Free Cash Flow
1 |
-16.9
|
-26.9
|
-11.3
|
-16.5
|
-47.7
|
-49
|
ROE (net income / shareholders' equity)
|
-5.42%
|
-3.39%
|
1.78%
|
9.71%
|
8.48%
|
0.89%
|
ROA (Net income/ Total Assets)
|
-2.74%
|
-0.31%
|
1.02%
|
4.64%
|
3.37%
|
0.94%
|
Assets
1 |
628.6
|
3,790
|
500.7
|
638.5
|
839.8
|
328.6
|
Book Value Per Share
2 |
12.10
|
11.70
|
11.90
|
13.10
|
14.30
|
14.40
|
Cash Flow per Share
2 |
0.1900
|
0.2100
|
0.1700
|
0.2800
|
0.2300
|
0.1200
|
Capex
1 |
29.3
|
16.9
|
13.2
|
12.7
|
13
|
23.2
|
Capex / Sales
|
3.76%
|
2.13%
|
1.47%
|
1.6%
|
1.14%
|
2.07%
|
Announcement Date
|
03/09/18
|
29/08/19
|
04/09/20
|
06/09/21
|
05/09/22
|
07/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -8.33% | 31.49M | | +20.77% | 68.72B | | -4.97% | 46.48B | | +24.89% | 44.63B | | +33.02% | 28.07B | | +8.74% | 19.25B | | +15.57% | 17.26B | | -12.49% | 15.12B | | -29.11% | 14.16B | | -31.12% | 12.22B |
Other Specialty Chemicals
|